BioSpace News Archive

Immuron Limited is pleased to announce record half yearly sales of its over-the-counter gastrointestinal and digestive health immune supplement Travelan®.

Cognigenics, Inc. is proud to announce the appointment of David Pyrce as its new Chief Executive Officer.

ASCEND Cardiovascular’s newest technology, Catalyst LIVE, currently implemented at two pioneering hospital sites, has pilots underway since 2022 at Stanford Medicine Children’s Health in California and Cook County Health in Illinois.

ANI Pharmaceuticals, Inc. announced that it received U.S. Food and Drug Administration approval for the Abbreviated New Drug Application for Indomethacin Oral Suspension, USP.

Asensus Surgical, Inc. announced that Nagoya University Hospital in Japan has entered into an agreement to lease and utilize a Senhance® Surgical System in their Pediatric Surgery Department, at the end of December 2023.

NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced that it has received Qualified Infectious Disease Product and Fast Track designation from the US FDA for NRX-101 in the treatment of complicated urinary tract infections and pyelonephritis.

Augmedix, Inc. announced that it will participate in the Maxim Group Virtual Healthcare IT Conference on January 24, 2024.

EyePoint Pharmaceuticals, Inc. announced that the Company granted non-statutory stock options to a new employee as an inducement award outside the Company’s 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635.

Regeneron Pharmaceuticals, Inc. and Sanofi announced that the U.S. Food and Drug Administration has updated the label for Dupixent® in atopic dermatitis, adding efficacy and safety data for patients aged 12 years and older with atopic dermatitis with uncontrolled moderate-to-severe hand and/or foot involvement.

Eyenovia, Inc., a commercial-stage, ophthalmic company, announced that it has re-acquired the rights to MicroPine in the U.S. and Canada.